Perioperative care of the cocaine-abusing patient

Adams EH, Kozel NJ. Cocaine use in America: introduction and overview. NIDA Res Monogr 1985; 61: 1–7. Kauppila T, Mecke E, Pertovaara A. Enhancement of morphine-induced analgesia and attenuation of morphine-induced side-effects by cocaine in rats. Pharmacol Toxicol 1992; 71: 173–8. Kaiko RF, Kanner R, Foley KM, et al. Cocaine and morphine interaction in acute and chronic cancer pain. Pain 1987; 31: 35–45. Adlaf EM, Smart RG. The Ontario adult alcohol and other drug use survey 1977–1989. Addiction Research Foundation of Ontario 1989. Gawin FH, Ellinwood EH Jr. Cocaine and other stimulants. Action, abuse, and treatment. N Engl J Med 1988; 318: 1173–82. Fleming JA, Byck R, Barash PG. Pharmacology and therapeutic applications of cocaine. Anesthesiology 1990; 73: 518–31. Van Dyke C, Barash PG, Jatlow P, Byck R. Cocaine: plasma concentrations after intranasal application in man. Science 1976; 191: 859–61. Jatlow PI. Drug abuse profile: cocaine. Clin Chem 1987; 33: 66B-71B. Inaba T, Stewart DJ, Kalow W. Metabolism of cocaine in man. Clin Pharmacol Ther 1978; 23: 547–52. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 1990; 88: 325–31. Grannis FW Jr, Bryant C, Cqffaratti JD, Turner AF. Acute aortic dissection associated with cocaine abuse. Clin Cardiol 1988; 11: 572–4. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 1989; 321: 1557–62. Kissner D, Lawrence W, Selis J, et al. Crack lung: pulmonary disease caused by cocaine abuse. Am Rev Respir Dis 1976; 136: 1250–2. Hoffman CK, Goodman PC. Pulmonary edema in co-caine smokers. Radiology 1989; 172: 463–5. Levine SR, Welch KMA. Cocaine and stroke. Current concepts of cerebrovascular disease. Stroke 1987; 22: 25–9. Merigian KS, Roberts JR. Cocaine intoxication: hyperpyrexia, rhabdomyolysis and actue renal failure. Clin Toxicol 1987; 25: 135–48. Sharff JA. Renal infarction associated with intravenous co-caine use. Ann Emerg Med 1984; 13: 1145–7. Levy M, Koren G. Obstetric and neonatal effects of drug abuse, emerg Med Clin North Amer 1990; 8: 633–52. Finkle BS, McCloskey KL. The forensic toxicology of co-caine. NIDA Res Monogr 1977; 13: 153–92. Singh PP, Dimich I, Shamsi A. Intraoperative pulmonary oedema in a young cocaine smoker. Can J Anaesth 1994; 41: 961–4. Meyers EF. Cocaine toxicity during dacryocystorhinostomy. Arch Ophthalmol 1980; 98: 842–3. el-Din AS, Mostafa SM. Severe hypertension during anaesthesia for dacryocystorhinostomy. Anaesthesia 1985; 40: 787–9. Barash PG, Kopriva CJ, Langou R, et al. Is cocaine a sympathetic stimulant during general anesthesia? JAMA 1980; 243: 1437–9. Koehntop DE, Liao JC, Van Bergen FH. Effects of pharmacologic alterations of adrenergic mechanisms by cocaine, tropolone, aminophylline, and ketamine on epinephrine-induced arrhythmias during halothane-nitrous oxide anesthesia. Anesthesiology 1977; 46: 83–93. Chiu YC, Brecht K, Das Gupta DS, Mhoon E. Myocardial infarction with topical cocaine anesthesia for nasal surgery. Arch Otolaryngold Head Neck Surg 1986; 112: 988–90. Boylan J, Cheng D, Feindel C, Sandier A, Boylen P. Cocaine toxicity and isoflurane anaesthseia — haemodynamics and myocardial metabolism. Can J Anaesth 1992; 39: A27. Boylan J, Cheng DCH, Sandier AN, Feindel C, Carmichael F, Boylan P. Cocaine-Isoflurane interaction in swine: regional blood flow effects. Anesth Analg 1993; 76: S26. Jones TR. Cocaine and other drug interactions. Strategies for research on the interactions of drugs abuse. NIDA Res Monogr 1986; 68: 142–53. Antelman SM, Kocan D, Rowland N, de Giovanni L, Chioda LA. Amitriptyline provides long-lasting immunization against sudden cardiac death from cocaine. Eur J Pharmacol 1981; 69: 119–20. Tordoff SG, Stubbing JF, Linter SPK. Delayed excitatory reaction following interactino of cocaine and monoamine oxidase inhibitor (phenelzine). Br J Anaesth 1991; 66: 516–8. Gay GR. Clinical management of acute and chronic co-caine poisoning. Ann Emerg Med 1982; 11: 562–72. Rappolt RT, Gay GR, Inaba SD. Propranolol: a specific antagonist to cocaine. Clin Toxicol 1977; 10: 265–71. Gay GR, Loper KA. The use of labetalol in the management of cocaine crisis. Ann Emerg Med 1988; 17: 282–3. Pollan S, Tadjziechy M. Esmolol in the management of epinephrine- and cocaine-induced cardiovascular toxicity. Anesth Analg 1989; 69: 663–4. Hale SL, Alkes KJ, Rezkalla SH, Eisenhauer AC, Kloner RA. Nifedipine protects the heart from the acute deleterious effects of cocaine if administered before but not after cocaine. Circulation 1991; 83: 1437–43. Fekete M, Borsey J. Chlorpromazine-cocaine antagonism: its relation to changes of dopamine metabolism in the brain. Eur J Pharmacol 1971; 16: 171–5. Byck R, Ruskis A, Ungerer J, Jatlow P. Naloxone potentiates cocaine effect in man. Psychopharmacol Bull 1982; 18: 214–5.